Abu dhabi: M42 is committed to the sustainable future of global health – from Abu Dhabi to the world. The company’s strategy involves leveraging technology not as a mere tool but as a transformative force in co-designing the future of global health, with a focus on technology solutions such as AI and genomics to develop world-leading, precise, personalised, and preventive solutions. Across its network, M42 operates at the intersection of health and innovation. With every solution and breakthrough, M42 embodies its commitment to a future where health is accessible and prioritised for every individual.
According to Emirates News Agency, in November 2025, M42 and Oracle Health announced a strategic collaboration to advance healthy longevity and disease prevention by integrating pharmacogenomic insights directly into the point of care. Through this initiative, data from the Emirati Genome Programme will be incorporated into the electronic health record (EHR), enabling clinicians to access real-time, genetically informed prescribing guidance for safer, more effective treatments. Using the Oracle Health Foundation EHR, the partnership will enhance personalised, preventive care, while providing unified patient records and expanding secure, nationwide access to digital health services, strengthening the UAE’s leadership in precision medicine.
Additionally, in November 2025, M42 announced a strategic partnership with 10X Health (USA) and REVIV Global (UK) to launch 10XREVIV, a new venture designed to transform precision health, nutrition, and longevity in the UAE. Through this collaboration, M42 and 10XREVIV will introduce a first-of-its-kind Precision Nutrition System to the Middle East, combining genetic insights, blood biomarkers, and nutritional science through proprietary AI to deliver hyper-personalised health optimisation at scale.
In October 2025, M42 signalled its expansion into Saudi Arabia with the launch of M42 Saudi Arabia, formalised during the Global Health Exhibition in Riyadh. Building on a 12-year partnership with the Ministry of Health through the operation of more than 40 Diaverum renal care clinics across 33 cities, the new entity marks the next phase of collaboration aligned with Vision 2030. M42 Saudi Arabia will continue delivering high-quality renal services while exploring partnerships in advanced patient care, multi-omics, population health, and digital health integration.
Moreover, in October 2025, M42’s Abu Dhabi Health Data Services launched Jordan’s first Digital Health Centre, a virtual hospital connecting five remote hospitals to a central command centre in Alsalt. Developed with Presight and Jordan’s health and digital ministries, the initiative significantly improves access to specialist care through Tele ICU, Tele dialysis and Tele radiology, cutting imaging turnaround times by 86 percent and expanding virtual renal care capacity. With Phase 1 complete, ADHDS has been selected to extend the network to seven more hospitals, reinforcing Jordan’s leadership in digital health and establishing a model for scalable telehealth across the region.
In another significant development, in October 2025, M42 announced a collaboration with the Medical Tourism Association and Mastercard to expand global access to the UAE’s world-class healthcare system. Through the partnership, leading M42 facilities will be featured on the Better by MTA platform, making travel, payment and care planning easier for international patients. With Abu Dhabi ranked among the top medical tourism destinations, the platform will provide streamlined access to M42’s network, including Healthpoint and Imperial College London Diabetes and Endocrine Centre, and is set to scale from 1.3 million to up to three million users by the end of 2025.